Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
Condition(s):Immunoproliferative DisorderLast Updated:March 4, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Immunoproliferative DisorderLast Updated:March 4, 2008Completed
Condition(s):Acute Lymphoblastic Leukemia; Immune System Diseases; Immunoproliferative DisordersLast Updated:December 3, 2021No longer available
Condition(s):Acute Lymphoblastic Leukemia; Immune System Diseases; Immunoproliferative DisordersLast Updated:January 31, 2024Recruiting
Condition(s):Lymphoma; Lymphoma, B-Cell; Immune System Diseases; Immunoproliferative Disorders; Lymphatic DiseasesLast Updated:June 18, 2023Recruiting
Condition(s):Lymphoma; Immune System Diseases; Immunoproliferative Disorders; Lymphatic Diseases; Lymphoproliferative Disorders; Neoplasms; Cutaneous Lymphoma; Cutaneous Anaplastic Large Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Lymphomatoid Papulosis; Cutaneous T Cell Lymphoma; Gray Zone LymphomaLast Updated:September 6, 2023Recruiting
Condition(s):Neoplasms, Plasma Cell; Neoplasms by Histologic Type; Neoplasms; Hemostatic Disorders; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemorrhagic Disorders; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases; Multiple MyelomaLast Updated:February 21, 2024Not yet recruiting
Condition(s):Lymphoma, Mantle-Cell; Lymphoma; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Lymphoma, Non-Hodgkin; Lymphoma, B-CellLast Updated:April 21, 2023Withdrawn
Condition(s):Lymphoma; Lymphoma, Non-Hodgkin; Immune System Diseases; Immunoproliferative Disorders; Lymphatic Diseases; Lymphoproliferative Disorders; Neoplasms; Neoplasms by Histologic TypeLast Updated:September 14, 2023Recruiting
Condition(s):Multiple Myeloma; Neoplasm, Plasma Cell; Neoplasms by Histologic Type; Neoplasms; Hemostatic Disorder; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemorrhagic Disorders; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases; Antineoplastic Agents; Analgesics, Non-Narcotic; Analgesics; Sensory System Agents; Peripheral Nervous System Agents; Physiological Effects of DrugsLast Updated:February 16, 2023Active, not recruiting
Condition(s):Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Immune System Diseases; Immunoproliferative Disorders; Lymphatic Diseases; Lymphoproliferative Disorders; Neoplasms; Neoplasms by Histologic TypeLast Updated:November 18, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.